Personalized rehab shows promise for rare muscle diseases
NCT ID NCT01415219
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a personalized exercise program can improve daily function and quality of life for people with dermatomyositis or polymyositis, two rare diseases that cause muscle weakness and inflammation. 80 adults with stable muscle impairment took part. The program focused on tailored exercises to improve strength and movement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
80 people
The number who actually took part.
- Start date
-
Mar 2008
- Finished
-
Dec 2013
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * diagnosis of Dermatomyositis ore polymyositis according to the International Myositis Assessment and Clinical Studies Group * functional impairment (an HAQ score greater than 0.5) * stability of muscle impairment * medical insurance Exclusion Criteria: * no recent inflammatory activity * other chronic disease * cognitive impairment * patients who participated to a rehabilitation program before inclusion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dermatomyositis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier universitaire de Rouen
Rouen, 76031, France
-
GH Pitié Salpétrière
Paris, 75651, France
-
Hopital Cochin
Paris, 75679, France
-
Hopital Rotschild
Paris, 75571, France
-
University Hospital, Lille
Lille, Hauts-de-France, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an oral drug calm inflamed muscles in myositis?
- Can a new pill ease muscle weakness in myositis?
- Can better sleep ease pain in teens with rheumatic disease?
- Can a targeted immune drug calm rare muscle inflammation?
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Can a skin biopsy tell your doctor which treatment will work?